Cromoglicate Adjunctive Therapy for Outpatients With Schizophrenia
Recruiting
Phase 1
Phase 2
Interventional Study
Schizophrenia
Schizo Affective Disorder
Prior Safety Data
This treatment has already been tested in at least one earlier human trial.
At a Glance
- Age
- 18 – 65
- Sex
- Any
- Trial phase
- Phase 1/2
- Study type
- Interventional
- Purpose
- Treatment
- Participants needed
- 160 (estimated)
- Sponsor
- Vishwajit Nimgaonkar, MD PhD · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
This is a double blind adjunctive randomized controlled trial for schizophrenia using cromoglicate.
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
* Written informed consent.
* Both genders, ages 18-60 years
* Schizophrenia / schizoaffective disorder (DSM V).
* Treated with the same APD for at least 60 days; Stable dose of APD for \> 1 month, continued throughout the study.
* PANSS total score of 60 and Score 4 or more on …
Contacts